Stock listing
Neumora Therapeutics, Inc.
Selected listing: NMRA · NASDAQ · USD · US
Neumora Therapeutics, Inc. (NASDAQ:NMRA), Health Technology. Latest release Aug 14, 2026: Neumora Therapeutics Reports Second Quarter 2026 Financial Results…
- Ticker
- NASDAQ:NMRA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. (ticker: NMRA) is a public company based in the United States, focusing on innovative therapeutic solutions. The company aims to address significant unmet medical needs through its research and development efforts.
Latest news from Neumora Therapeutics, Inc.
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 14, 2026
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
July 27, 2026
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
June 15, 2026
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
May 12, 2026
Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Events
Research Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. company profile
View the public company page for Neumora Therapeutics, Inc. on 6ix.
Neumora Therapeutics, Inc. news
Read company news and market updates connected to Neumora Therapeutics, Inc..
Neumora Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Neumora Therapeutics, Inc..